Evidence map›Paper›PMID 18815219›Full record

ArticleAmerican journal of physiology. Renal physiology2008

p53 regulates renal expression of HIF-1{alpha} and pVHL under physiological conditions and after ischemia-reperfusion injury.

Timothy A Sutton, Jared Wilkinson, Henry E Mang, Nicole L Knipe, Zoya Plotkin, Maya Hosein, Katelyn Zak, Jeremy Wittenborn, Pierre C Dagher

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Renal physiology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Novel roles for mucin 1 in the kidney.Current opinion in nephrology and hypertension · 2017
    Review
  5. Article
  6. Article
  7. Article
  8. Muc1 is protective during kidney ischemia-reperfusion injury.American journal of physiology. Renal physiology · 2015
    Article
  9. Article
  10. TIGAR regulates glycolysis in ischemic kidney proximal tubules.American journal of physiology. Renal physiology · 2015
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Pathogenesis of acute kidney injury: foundation for clinical practice.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2011
    Review
  17. Review
  18. Article
  19. Article
  20. HIF-1 mediates pathogenic inflammatory responses to intestinal ischemia-reperfusion injury.American journal of physiology. Gastrointestinal and liver physiology · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Timothy A SuttonDiv. of Nephrology, Dept. of Medicine, Indiana Univ. School of Medicine, 950 West Walnut St., R-II, 202, Indianapolis, IN 46202, USA. tsutton2@iupui.edu
Jared Wilkinson
Henry E Mang
Nicole L Knipe
Zoya Plotkin
Maya Hosein
Katelyn Zak
Jeremy Wittenborn
Pierre C Dagher
Indiana University Bloomington · USIndiana University School of Medicine

Funding

PROBE DELIVERY COREP30DK079312 · NIDDK · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI MOLITORIS, BRUCE A · 2007 to 2021
$17.1M
Mechanisms of microvascular damage in acute kidney injuryR01DK077124 · NIDDK · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI SUTTON, TIMOTHY ALAN · 2007 to 2011
$1.3M
Role of guanine nucleotides in ischemic renal injuryR01DK060495 · NIDDK · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI DAGHER, PIERRE C · 2002 to 2006
$1.1M
NIDDK NIH HHS DK-60,495NIDDK NIH HHS DK-77,124NIDDK NIH HHS DK-79,312NIDDK NIH HHS R01 DK077124
6 · The paper itself

Abstract

Ischemia-reperfusion injury (IRI) is a common cause of acute kidney injury (AKI) and is characterized by widespread tubular and microvascular damage. The tumor suppressor p53 is upregulated after IRI and contributes to renal injury in part by promoting apoptosis. Acute, short-term inhibition of p53 with pifithrin-alpha conveys significant protection after IRI. The hypoxia-inducible factor-1 (HIF-1) pathway is also activated after IRI and has opposing effects to those promoted by p53. The balance between the HIF-1 and p53 responses can determine the outcome of IRI. In this manuscript, we investigate whether p53 regulates the HIF-1 pathway in a rodent model of IRI. HIF-1alpha is principally expressed in the collecting tubules (CT) and thick ascending limbs (TAL) under physiological conditions. However, inhibition of p53 with pifithrin-alpha increases the faint expression of HIF-1alpha in proximal tubules (PT) under physiological conditions. Twenty-four hours after IRI, HIF-1alpha expression is decreased in both CT and TAL. HIF-1alpha expression in the PT is not significantly altered after IRI. Acute inhibition of p53 significantly increases HIF-1alpha expression in the PT after IRI. Additionally, pifithrin-alpha prevents the IRI-induced decrease in HIF-1alpha in the CT and TAL. Parallel changes are observed in the HIF-1alpha transcriptive target, carbonic anhydrase-9. Finally, inhibition of p53 prevents the dramatic changes in Von Hippel-Lindau protein morphology and expression after IRI. We conclude that activation of p53 after IRI mitigates the concomitant activation of the protective HIF-1 pathway. Modulating the interactions between the p53 and HIF-1 pathway can provide novel options in the treatment of AKI.

Indexed as

Acute Kidney InjuryAnimalsBenzothiazolesCell LineHypoxia-Inducible Factor 1, alpha SubunitKidney CortexKidney MedullaKidney TubulesMaleMicroscopy, ConfocalRatsRats, Sprague-DawleyReperfusion InjuryTolueneTumor Suppressor Protein p53Up-RegulationBenzothiazolesHif1a protein, ratHypoxia-Inducible Factor 1, alpha SubunitpifithrinTolueneTumor Suppressor Protein p53Von Hippel-Lindau Tumor Suppressor Protein

Identifiers

PMID18815219
PMCPMC2604829
OpenAlexW2140884973

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.